osama zaidat 600 400

EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes of the device, 80.2% patients in the study achieved mTICI 2b–3 grade revascularisation in the target vessel. The results were presented at International Stroke Conference (ISC; 24–26 January 2018, Los Angeles, USA)
NeuroNews

Write to us
Editorial: Jamie Bell jamie@bibamedical.com
Advertising: Michael Broughton michael@bibamedical.com


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy